$4.74
3.72% yesterday
Nasdaq, Aug 25, 10:17 pm CET
ISIN
NL0015000DX5
Symbol
ATAI

ATAI Life Sciences N.V. Stock price

$4.74
+1.17 32.77% 1M
+3.02 175.58% 6M
+3.41 256.39% YTD
+3.43 261.83% 1Y
-0.13 2.67% 3Y
-14.71 75.63% 5Y
-14.71 75.63% 10Y
-14.71 75.63% 20Y
Nasdaq, Closing price Mon, Aug 25 2025
+0.17 3.72%
ISIN
NL0015000DX5
Symbol
ATAI
Industry

Key metrics

Basic
Market capitalization
$1.0b
Enterprise Value
$926.2m
Net debt
positive
Cash
$95.9m
Shares outstanding
212.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
439.8 | 433.2
EV/Sales
401.0 | 395.0
EV/FCF
negative
P/B
7.1
Financial Health
Equity Ratio
73.0%
Return on Equity
-128.4%
ROCE
-41.0%
ROIC
-76.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.3m | $2.3m
EBITDA
$-66.4m | $-95.1m
EBIT
$-67.1m | $-96.2m
Net Income
$-80.5m | $-101.6m
Free Cash Flow
$-81.8m
Growth (TTM | estimate)
Revenue
507.9% | 656.5%
EBITDA
38.4% | 4.2%
EBIT
37.9% | 3.6%
Net Income
-38.5% | 31.9%
Free Cash Flow
-3.3%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,869.2% | -4,056.1%
EBIT
-2,901.7%
Net
-3,476.5% | -4,333.8%
Free Cash Flow
-3,535.3%
More
EPS
$-0.4
FCF per Share
$-0.4
Short interest
9.6%
Employees
54
Rev per Employee
$10.0k
Show more

Is ATAI Life Sciences N.V. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

ATAI Life Sciences N.V. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a ATAI Life Sciences N.V. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a ATAI Life Sciences N.V. forecast:

Buy
93%
Hold
7%

Financial data from ATAI Life Sciences N.V.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2.31 2.31
508% 508%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 35 35
38% 38%
1,526%
- Research and Development Expense 34 34
33% 33%
1,481%
-66 -66
38% 38%
-2,874%
- Depreciation and Amortization 0.75 0.75
121% 121%
32%
EBIT (Operating Income) EBIT -67 -67
38% 38%
-2,907%
Net Profit -80 -80
39% 39%
-3,483%

In millions USD.

Don't miss a Thing! We will send you all news about ATAI Life Sciences N.V. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ATAI Life Sciences N.V. Stock News

Positive
Proactive Investors
12 days ago
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) has reflected on a “transformational” first half of 2025, marked by a series of clinical and corporate milestones, including positive topline data from its Phase 2b trial of BPL-003 for treatment-resistant depression. The randomized, quadruple-masked global study enrolled 193 patients and met its primary and all key secondary endpoints.
Neutral
Seeking Alpha
29 days ago
Despite the phase 2b failure of inidascamine for CIAS, I maintain a Buy on Atai due to its diversified psychedelic pipeline. Beckley Psytech's BPL-003 drug for treatment-resistant depression showed strong phase 2b results, with rapid and sustained efficacy, and could be phase 2 program with FDA allowance. The pending merger with Beckley Psytech and upcoming catalysts, including FDA meetings and...
Neutral
Proactive Investors
29 days ago
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) said on Friday that its platform company, Recognify Life Sciences, reported top-line results from a Phase 2b trial of inidascamine in cognitive impairment associated with schizophrenia (CIAS), which did not meet the primary endpoint but demonstrated consistent signs of cognitive and functional benefit and maintained a favorable safety profile. The doubl...
More ATAI Life Sciences N.V. News

Company Profile

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Head office Netherlands
CEO Dr. Rao
Employees 54
Founded 2018
Website atai.life

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today